US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi’s bleeding disorder therapy

By Sriparna Roy and Padmanabhan Ananthan(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi’s hemophilia therapy, introducing a new type of treatment administered every two months for patients with the rare blood clotting disorder,...
H&M reports sluggish start to spring sales

H&M reports sluggish start to spring sales

By Helen ReidLONDON (Reuters) -H&M’s sales were up just 1% in March after a weaker than expected first quarter, the Swedish fast-fashion retailer reported on Thursday, in a sign of a slow start to its spring and summer season.H&M has ramped up marketing...